Episodi
-
Yesterday, Health Canada approved semaglutide 2.4mg (Wegovy) to reduce the risk of heart attacks in people with cardiovascular disease and overweight or obesity. This is a landmark moment in Canada. What does it mean for people with overweight or obesity and cardiovascular disease? Find out Dr. Sue's thoughts here!
Learn more: https://drsue.ca/2024/11/health-canada-approves-wegovy-to-reduce-risk-of-heart-attacks/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
What's new in the Diabetes Canada 2024 guideline on how to choose the best medication for diabetes?
Learn more: https://drsue.ca/2024/11/diabetes-canada-2024-pharmacotherapy-guidelines-update-whats-new/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Episodi mancanti?
-
Can tirzepatide (Mounjaro/Zepbound) provide long term weight loss, prevent diabetes, and treat heart failure with preserved ejection fraction? It's been a busy week - find out here!
Learn more: https://drsue.ca/2024/11/3-year-sustained-weight-loss-powerful-prevention-of-diabetes-and-heart-failure-benefit-with-tirzepatide-mounjaro-zepbound/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Knowing what to do to prepare a person using GLP1 based medication for surgeries requiring anesthesia or sedation remains a clinical conundrum. New multisociety clinical practice guidance was just published in an attempt to harmonize recommendations. What does this updated guidance tell us we should do?
Learn more: https://drsue.ca/2024/11/new-guidance-on-what-to-do-with-glp1-medications-before-surgery-or-sedation-whats-clear-and-whats-not/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Obesity-related knee osteoarthritis is caused not only by increased weight stress on the joints, but also by the chronic inflammatory state that is seen in obesity. Can weight management medication reduce pain? Find out about the results of a study of Wegovy in people with obesity and knee osteoarthritis here!
Learn more: https://drsue.ca/2024/11/knee-pain-from-osteoarthritis-can-weight-management-medication-help/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
The American Heart Association and American Stroke Association have just issued an updated guideline for prevention of stroke in people who have never had a stroke previously. Here are some of their Top10 that I found most interesting, as a diabetes/hormone/obesity specialist!
Learn more: https://drsue.ca/2024/10/whats-new-in-stroke-prevention-guidelines-my-top-5/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
While some people seem to celebrate being able to get by with less sleep, the negative impact of insufficient sleep on metabolic health is largely underappreciated. Just how does insufficient sleep drive metabolic disease and weight gain? Read on to find out!
Learn more: https://drsue.ca/2024/10/why-does-poor-sleep-drive-weight-and-blood-sugars-up/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Are ADHD and obesity connected? Yes - and it's a two-way street. Find out more here!
Learn more: https://drsue.ca/2024/10/are-adhd-and-obesity-connected/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
We are now very well acquainted with the efficacy of GLP1 receptor agonists (GLP1RAs) in weight management, like semaglutide (Wegovy/Ozempic) and liraglutide (Saxenda), and the dual GLP1/GIP agonist tirzepatide (Zepbound/Mounjaro). What is GLP2 (yes two), and could GLP2 receptor agonism be an untapped frontier in weight management medication?
Learn more: https://drsue.ca/2024/09/could-glp2-receptor-agonists-be-a-new-frontier-in-weight-management-medication/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Why is type 2 diabetes on the rise in younger people, why does it matter, and what can we do about it? Listen on to find out!
Learn more: https://drsue.ca/2024/09/sounding-the-alarm-the-rising-tide-of-younger-onset-type-2-diabetes/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Could finerenone (kerendia) be a much-needed addition to the treatment approach in people with HFpEF? Find out here!
Learn more: https://drsue.ca/2024/09/does-finerenone-kerendia-reduce-heart-failure-events-in-people-with-heart-failure-with-preserved-ejection-fraction-hfpef/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Some doctors and researchers are keen on the idea of inducing diabetes remission with lifestyle changes. A real-life implementation of the DiRECT lifestyle remission protocol was implemented in the UK. Was it successful, and what have we learned? Hint: People don't fail diets. Diets fail people. Read on!
Learn more: https://drsue.ca/2024/09/diabetes-remission-with-lifestyle-intervention-have-we-learned-anything/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Could women have reproductive concerns related to elevated weight that is NOT PCOS? Introducing FOSH.
Learn more: https://drsue.ca/2024/08/could-women-with-obesity-have-a-cause-of-infrequent-periods-or-fertility-concerns-that-is-not-pcos-introducing-fosh/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Semaglutide (Ozempic/Wegovy) reduces not only appetite, but also the reward experience of food and possibly even alcohol in our brains. Could it also make people less inclined to smoke?
Learn more: https://drsue.ca/2024/08/could-ozempic-reduce-the-likelihood-of-nicotine-use/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Metreleptin is a human leptin analog, now approved and available in Canada for treatment of lipodystrophy. Learn more here!
Learn more: https://drsue.ca/2024/08/leptin-analog-for-treatment-of-lipodystrophy-now-available-in-canada/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Could your statin cholesterol medication cause diabetes? If you have diabetes, how much might your sugars rise with statin therapy?
Learn more: https://drsue.ca/2024/08/could-your-statin-cholesterol-medication-cause-diabetes/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
One in three Canadian adults will get shingles at some point in their life. Shingles can be extremely painful, can occur in devastating locations, and can cause debilitating pain that can last months afterwards. Learn about the vaccine that can powerfully reduce the risk of getting shingles here!
Learn more: https://drsue.ca/2024/07/should-you-get-the-shingles-vaccine/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Only a small fraction of people who may benefit from weight management medication are actually being prescribed treatment. What are the barriers to use of weight management medication, and how can we overcome them?
Learn more: https://drsue.ca/2024/07/what-are-the-barriers-to-use-of-weight-management-medication-and-how-can-we-overcome-them/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
Once weekly basal (long acting) insulin is now available in Canada - the first country in the world to start using it. Find out more about insulin icodec (Awiqli) here!
Learn more: https://drsue.ca/2024/07/once-weekly-insulin-now-available-in-canada/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. -
A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop?
Learn more: https://drsue.ca/2024/07/can-semaglutide-ozempic-wegovy-cause-loss-of-vision/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals. - Mostra di più
